5 healthy stocks for your portfolio

The healthcare sector is expanding, but which companies are worth your consideration?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investing in the healthcare sector certainly holds its risks. The success of companies relies heavily upon the quality of the products they offer to the market, their ability to expand into new markets and government regulations, to name just a few.

However, some of the companies on the market also hold enormous potential to drive earnings and profit well into the future, based on new research or developed products. The Australian Financial Review has highlighted a number of health stocks that are worth your attention.

Sirtex Medical (ASX: SRX) is a biotechnology company focused on manufacturing and distributing liver cancer treatments. Whilst it has delivered outstanding growth over the last few years, the market battered down its price after the company realised only 6.1% growth in sales of its liver cancer treatment drug for the third quarter, compared to 34% growth in the previous corresponding period. Having more than doubled in price over the last year and sitting at $12.20 with a P/E ratio of 29, it is quite expensive at today’s price, however, it is definitely worth your consideration should the share price fall anytime soon.

Acrux (ASX: ACR) has a primary focus on treating men with low levels of testosterone with its spray-on medicine called Axiron. Offering a 2.2% dividend yield, Acrux has given its licensing partner, Eli Lilly, outstanding returns in recent times. Trading on a P/E of 41, the market is anticipating strong earnings to continue well into the future, however, Macquarie Private Wealth is a little more reserved on its potential. Whilst they are concerned that market growth could begin to slow down, a reduction in rebate in the US could also take away from Acrux’s competitive advantage in the industry.

The prospects of infection control developer Nanosonics (ASX: NAN) were also highlighted. With its Trophon product (an ultrasound probe disinfection system) gaining in popularity, the company’s share price has gained 50% since the beginning of May. Whilst its sales declined by 13% for 1H 2013, it is expected that it will benefit significantly from further global expansion – particularly the US and Europe.

Whilst Alchemia’s (ASX: ACL) and Virtus Health’s (ASX: VRT) prospects were also highlighted, other quality companies failed to receive a mention. Resmed (ASX: RMD), a manufacturer of respiratory disorder treatments, as well as Cochlear (ASX: COH), a manufacturer of cochlear implantable devices for the hearing impaired, have both proven themselves to be global leaders in their respective fields. Each of these corporations have enormous growth potential and are currently trading at very attractive prices.

Foolish takeaway

Just like with any other industry, there are risks involved in the healthcare sector. Although enormous gains can be made from companies that could potentially produce breakthrough technologies, a safer option may be to put your money with those that have already established themselves.

The Australian Financial Review says “good quality Australian shares that have a long history of paying dividends are a real alternative to a term deposit.” Get “3 Stocks for the Great Dividend Boom” in our special FREE report. Click here now to find out the names, stock symbols, and full research for our three favourite income ideas, all completely free!

More reading


Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

asx share price competitions represented by businessmen arm wrestling
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

person reading news on mobile phone
⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »